Zinc (picolinate vs gluconate vs bisglycinate) and immune

What 5 graded rows on zinc (picolinate vs gluconate vs bisglycinate) agree on for immune, and where they differ. Counted side by side, never averaged.

What the rows agree on

Each block and row is one graded row from the Zinc (picolinate vs gluconate vs bisglycinate) page, with its PubMed record.

Your question

Supplement
Zinc (picolinate vs gluconate vs bisglycinate) Choose another

Zinc (picolinate vs gluconate vs bisglycinate) and immune

5 rows · 2,463 people

Split. 3 rows found an improvement, 1 found no difference and 1 had mixed results.

No difference or mixed
Improved
Each block is one evidence row, sized by how many people it enrolled, with its grade inside. Outlined: mixed results.
  • Grade B× 1
  • Grade C× 1
  • Grade D× 3
Rows
5
Trials
5
At least: a review without a trial count
People
2,463
Pooled reviews may count some twice

Where they differ

From the rows
Trial sizeWho was studiedGrade

The best-graded row, grade B, is a systematic review of 972 people (2024) and found an improvement.

The row that found no difference was larger: 1,449 people, against a median of 15 people for the 3 rows that found an improvement.

Only the 3 rows that found an improvement name women in their population.

The best grade is B among the rows that found an improvement, and C among the row that found no difference.

1 row with mixed results is left out of this comparison.

The rows

3 improved · 1 no difference · 1 mixed
  1. Grade BLength of a cold when zinc is started after symptoms begin · Improved

    Systematic review · n 972 · 2024 · 8 treatment trials in people with the common cold

    Zinc gluconate lozenges 45–276 mg/day across lozenge trials · 4.5–21 days

    Colds were 2.37 days shorter on average (MD -2.37; 95% CI -4.21 to -0.53), low-certainty evidence with very high heterogeneity (I² 97%). Non-serious side effects such as nausea were more common with zinc (RR 1.34).

    Row on the Zinc (picolinate vs gluconate vs bisglycinate) page · PubMed 38719213 (opens PubMed)

  2. Grade DZinc status markers: picolinate vs citrate vs gluconate · Improved

    Crossover RCT · n 15 · 1987 · Healthy volunteers

    50 mg elemental zinc/day · 4 weeks per period

    Hair, urine and red-blood-cell zinc rose significantly only with picolinate; none changed with citrate, gluconate or placebo. Serum zinc did not rise significantly with any form.

    Row on the Zinc (picolinate vs gluconate vs bisglycinate) page · PubMed 3630857 (opens PubMed)

  3. Grade DZinc absorption: bisglycinate vs gluconate · Improved

    PK study · n 12 · 2007 · Healthy female volunteers

    15 mg elemental zinc, single administration · Single doses with a 7-day washout

    Bisglycinate gave 43.4% higher oral bioavailability of zinc than gluconate, based on serum zinc levels.

    Row on the Zinc (picolinate vs gluconate vs bisglycinate) page · PubMed 18271278 (opens PubMed)

  4. Grade CChance of catching a cold with regular zinc · No difference

    Systematic review · n 1,449 · 2024 · 9 prevention trials

    Varied across trials · Up to 5–18 months of follow-up in some trials

    Little or no reduction in the risk of developing a cold (RR 0.93; 95% CI 0.85 to 1.01), low-certainty evidence.

    Row on the Zinc (picolinate vs gluconate vs bisglycinate) page · PubMed 38719213 (opens PubMed)

  5. Grade DZinc absorption: citrate vs gluconate vs oxide · Mixed

    Crossover RCT · n 15 · 2014 · Healthy young adults, fasting

    10 mg elemental zinc, single test doses · Single-dose isotope tests

    Median fractional absorption was 61.3% from citrate and 60.9% from gluconate (no difference), but 49.9% from oxide (significantly lower). Three participants absorbed little or no zinc from oxide.

    Row on the Zinc (picolinate vs gluconate vs bisglycinate) page · PubMed 24259556 (opens PubMed)

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.